Funding for this research was provided by:
State Key Laboratory of Pathogenesis, Prevention and Treatment of Central Asian High Incidence Diseases Fund (SKL-HIDCA-2020-13)
Article History
Received: 22 March 2022
Accepted: 28 April 2022
First Online: 1 July 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: All procedures involving human participants were performed in accordance with the ethical standards of the Institutional and National Research Committee, and with the Declaration of Helsinki. Ethical approval was obtained from the Ethical Committee of the Affiliated Tumor Hospital of Xinjiang Medical University.
: Subjects signed the informed consent.